 | • レポートコード：GIR-105X00910 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、筋萎縮性側索硬化症（ALS）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。筋萎縮性側索硬化症（ALS）の種類別市場規模（リルゾール、エダラボン（ラディカバ）、その他）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・筋萎縮性側索硬化症（ALS）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Mitsubishi Tanabe Pharma、Sanofi、Mylan Pharma、Apotex、Glemark Generics、Covis Pharma、Sun Pharma、Lunan Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リルゾール、エダラボン（ラディカバ）、その他 ・用途別分析2016年-2026年：病院、ドラッグストア、その他 ・筋萎縮性側索硬化症（ALS）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・筋萎縮性側索硬化症（ALS）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・筋萎縮性側索硬化症（ALS）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・筋萎縮性側索硬化症（ALS）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・筋萎縮性側索硬化症（ALS）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Amyotrophic Lateral Sclerosis (ALS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Amyotrophic Lateral Sclerosis (ALS) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Amyotrophic Lateral Sclerosis (ALS) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Amyotrophic Lateral Sclerosis (ALS) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Riluzole
Edaravone (Radicava)
Other
Market segment by Application can be divided into
Hospital
Drugs Store
Other
The key market players for global Amyotrophic Lateral Sclerosis (ALS) market are listed below:
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Amyotrophic Lateral Sclerosis (ALS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Amyotrophic Lateral Sclerosis (ALS) Market Size & Forecast
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value (2016-2026))
1.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume (2016-2026)
1.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2016-2026) & (USD/MT)
1.5 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity Analysis
1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Total Production Capacity (2016-2026)
1.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Amyotrophic Lateral Sclerosis (ALS) Market Drivers
1.6.2 Amyotrophic Lateral Sclerosis (ALS) Market Restraints
1.6.3 Amyotrophic Lateral Sclerosis (ALS) Trends Analysis
2 Manufacturers Profiles
2.1 Mitsubishi Tanabe Pharma
2.1.1 Mitsubishi Tanabe Pharma Details
2.1.2 Mitsubishi Tanabe Pharma Major Business
2.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan Pharma
2.3.1 Mylan Pharma Details
2.3.2 Mylan Pharma Major Business
2.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business
2.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Glemark Generics
2.5.1 Glemark Generics Details
2.5.2 Glemark Generics Major Business
2.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Covis Pharma
2.6.1 Covis Pharma Details
2.6.2 Covis Pharma Major Business
2.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business
2.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lunan Pharma
2.8.1 Lunan Pharma Details
2.8.2 Lunan Pharma Major Business
2.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturer
3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Amyotrophic Lateral Sclerosis (ALS)
3.4 Market Concentration Rate
3.4.1 Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share
3.4.2 Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share
3.5 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Amyotrophic Lateral Sclerosis (ALS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region
4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2016-2026)
4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2016-2026)
4.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026)
4.3 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026)
4.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026)
4.5 South America Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026)
4.6 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Type (2016-2026)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2016-2026)
5.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Application (2016-2026)
6.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2016-2026)
6.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2026)
7.2 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2026)
7.3 North America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
7.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2016-2026)
7.3.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2026)
8.2 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2026)
8.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
8.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2016-2026)
8.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2026)
9.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2026)
9.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size by Region
9.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2026)
10.2 South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2026)
10.3 South America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
10.3.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2016-2026)
10.3.2 South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2026)
11.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2026)
11.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
11.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Amyotrophic Lateral Sclerosis (ALS) Typical Distributors
12.3 Amyotrophic Lateral Sclerosis (ALS) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application, (USD Million), 2021-2026
Table 3. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Mitsubishi Tanabe Pharma Major Business
Table 5. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 6. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 10. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Pharma Major Business
Table 13. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 14. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Apotex Basic Information, Manufacturing Base and Competitors
Table 16. Apotex Major Business
Table 17. Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 18. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Glemark Generics Basic Information, Manufacturing Base and Competitors
Table 20. Glemark Generics Major Business
Table 21. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 22. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Covis Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Covis Pharma Major Business
Table 25. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 26. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharma Major Business
Table 29. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 30. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lunan Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Lunan Pharma Major Business
Table 33. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 34. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturer (2019-2021e) & (K MT)
Table 36. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Amyotrophic Lateral Sclerosis (ALS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Company, (K MT): 2020 VS 2021
Table 39. Head Office and Amyotrophic Lateral Sclerosis (ALS) Production Site of Key Manufacturer
Table 40. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2016-2021e) & (K MT)
Table 41. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2021-2026) & (K MT)
Table 42. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2021e) & (K MT)
Table 45. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2021-2026) & (K MT)
Table 46. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2016-2021e) & (USD/MT)
Table 49. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2021-2026) & (USD/MT)
Table 50. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2021e) & (K MT)
Table 51. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2021-2026) & (K MT)
Table 52. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2016-2021e) & (USD/MT)
Table 55. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2021-2026) & (USD/MT)
Table 56. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2016-2021e) & (K MT)
Table 57. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2021-2026) & (K MT)
Table 58. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2021e) & (K MT)
Table 61. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2021-2026) & (K MT)
Table 62. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2021e) & (K MT)
Table 63. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2021-2026) & (K MT)
Table 64. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2016-2021e) & (K MT)
Table 65. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2021-2026) & (K MT)
Table 66. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2021e) & (K MT)
Table 69. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2021-2026) & (K MT)
Table 70. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2021e) & (K MT)
Table 71. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2021-2026) & (K MT)
Table 72. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2016-2021e) & (K MT)
Table 73. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2021-2026) & (K MT)
Table 74. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2021e) & (K MT)
Table 77. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2021-2026) & (K MT)
Table 78. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2021e) & (K MT)
Table 79. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2021-2026) & (K MT)
Table 80. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2016-2021e) & (K MT)
Table 81. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2021-2026) & (K MT)
Table 82. South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2021e) & (K MT)
Table 85. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2021-2026) & (K MT)
Table 86. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2021e) & (K MT)
Table 87. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2021-2026) & (K MT)
Table 88. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2016-2021e) & (K MT)
Table 89. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2021-2026) & (K MT)
Table 90. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2016-2021e) & (K MT)
Table 93. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2021-2026) & (K MT)
Table 94. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2016-2021e) & (K MT)
Table 95. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2021-2026) & (K MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Amyotrophic Lateral Sclerosis (ALS) Typical Distributors
Table 99. Amyotrophic Lateral Sclerosis (ALS) Typical Customers
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Picture
Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type in 2020
Figure 3. Riluzole
Figure 4. Edaravone (Radicava)
Figure 5. Other
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Drugs Store
Figure 9. Other
Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales (2016-2026) & (K MT)
Figure 32. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity (2016-2026) & (K MT)
Figure 33. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Amyotrophic Lateral Sclerosis (ALS) Market Drivers
Figure 35. Amyotrophic Lateral Sclerosis (ALS) Market Restraints
Figure 36. Amyotrophic Lateral Sclerosis (ALS) Market Trends
Figure 37. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturer in 2020
Figure 38. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Manufacturer in 2020
Figure 39. Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2016-2026)
Figure 43. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2016-2026)
Figure 44. North America Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026) & (USD Million)
Figure 45. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026) & (USD Million)
Figure 47. South America Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue (2016-2026) & (USD Million)
Figure 49. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2016-2026)
Figure 50. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2016-2026)
Figure 51. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2016-2026)
Figure 53. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2016-2026)
Figure 54. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2016-2026)
Figure 56. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2016-2026)
Figure 57. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2016-2026)
Figure 58. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2016-2026)
Figure 59. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2016-2026)
Figure 60. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2016-2026)
Figure 61. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2016-2026)
Figure 62. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2016-2026)
Figure 67. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2016-2026)
Figure 68. South America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2016-2026)
Figure 69. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2016-2026)
Figure 70. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の多発性硬化症治療薬市場 2021：企業別、地域別、種類・用途別 The Multiple Sclerosis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 多発性硬化症に対する幹細胞療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 世界の汎用ラテラルカップリング市場 2021：企業別、地域別、種類・用途別 The Universal Lateral Couplings market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 多発性硬化症治療薬の世界市場2018-2025 Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
- 世界の自動車用横位置照明器具市場 2021：企業別、地域別、種類・用途別 The Automotive Lateral Position Lighting Fixtures market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…